These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14602208)

  • 1. Protection of pigs against 'in contact' challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus.
    Hammond JM; Jansen ES; Morrissy CJ; Hodgson AL; Johnson MA
    Virus Res; 2003 Nov; 97(2):151-7. PubMed ID: 14602208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and sub-cutaneous vaccination of commercial pigs with a recombinant porcine adenovirus expressing the classical swine fever virus gp55 gene.
    Hammond JM; Jansen ES; Morrissy CJ; Williamson MM; Hodgson AL; Johnson MA
    Arch Virol; 2001; 146(9):1787-93. PubMed ID: 11699963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
    Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
    Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever.
    Hammond JM; McCoy RJ; Jansen ES; Morrissy CJ; Hodgson AL; Johnson MA
    Vaccine; 2000 Jan; 18(11-12):1040-50. PubMed ID: 10590324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever.
    Hammond JM; Jansen ES; Morrissy CJ; Goff WV; Meehan GC; Williamson MM; Lenghaus C; Sproat KW; Andrew ME; Coupar BE; Johnson MA
    Vet Microbiol; 2001 May; 80(2):101-19. PubMed ID: 11295331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
    de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
    Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.
    de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
    Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prime-boost vaccination strategy using a Semliki Forest virus replicon vectored DNA vaccine followed by a recombinant adenovirus protects pigs from classical swine fever].
    Sun Y; Liu D; Wang Y; Li N; Li H; Liang B; Qiu H
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):679-85. PubMed ID: 19670635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge.
    Madera R; Gong W; Wang L; Burakova Y; Lleellish K; Galliher-Beckley A; Nietfeld J; Henningson J; Jia K; Li P; Bai J; Schlup J; McVey S; Tu C; Shi J
    BMC Vet Res; 2016 Sep; 12(1):197. PubMed ID: 27612954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.
    van Gennip HG; Bouma A; van Rijn PA; Widjojoatmodjo MN; Moormann RJ
    Vaccine; 2002 Feb; 20(11-12):1544-56. PubMed ID: 11858861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of pigs against classical swine fever with DNA-delivered gp55.
    Andrew ME; Morrissy CJ; Lenghaus C; Oke PG; Sproat KW; Hodgson AL; Johnson MA; Coupar BE
    Vaccine; 2000 Mar; 18(18):1932-8. PubMed ID: 10699343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunisation of swine with a classical swine fever vaccine (Chinese strain) and transmission studies in rabbits and sheep.
    Chenut G; Saintilan AF; Burger C; Rosenthal F; Crucière C; Picard M; Bruyère V; Albina E
    Vet Microbiol; 1999 Feb; 64(4):265-76. PubMed ID: 10063532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
    Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR
    Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promising multiple-epitope recombinant vaccine against classical swine fever virus.
    Tian H; Hou X; Wu J; Chen Y; Shang Y; Yin S; Zhang K; Liu X
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):59-64. PubMed ID: 24269058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
    Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
    Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.